scispace - formally typeset
S

Sung Han Yoon

Researcher at Cedars-Sinai Medical Center

Publications -  21
Citations -  1751

Sung Han Yoon is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Valve replacement & Aortic valve. The author has an hindex of 13, co-authored 21 publications receiving 1175 citations. Previous affiliations of Sung Han Yoon include Asan Medical Center & Keio University.

Papers
More filters
Journal ArticleDOI

Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis

TL;DR: In this article, the authors compared the procedural and clinical outcomes in patients with bicuspid versus tricusid aortic valve stenosis (AS) from the BICUSID AS TAVR multicenter registry.
Journal ArticleDOI

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

Sung Han Yoon, +65 more
TL;DR: The TMVR provided excellent outcomes for patients with degenerated bioprostheses despite high surgical risk, however, ViR and ViMAC were associated with higher rates of adverse events and mid-term mortality compared with ViV.
Journal ArticleDOI

Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation

Sung Han Yoon, +63 more
TL;DR: TAVR using the new-generation devices was associated with improved procedural outcomes in treating patients with pure native AR, and significant post-procedural AR was independently associated with increased mortality.
Journal ArticleDOI

Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.

TL;DR: In this paper, the authors evaluated the outcomes of transcatheter mitral valve replacement in patients with failed mitral bioprosthetic valves (ViV) and annuloplasty rings (valve-in-ring [ViR]).
Journal ArticleDOI

Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.

TL;DR: New-generation devices were associated with less paravalvular leak and, hence, a higher device success rate than early- Generation devices, and the clinical outcomes of TAVR in patients with bicuspid AS were favorable.